{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:44:47Z","timestamp":1792842287093,"version":"4.5.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03115-6","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T15:53:14Z","timestamp":1746201194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Application of a Two-Phase Experiment Design and Optimization Method to Formulate Ciprofloxacin-Loaded Bovine Serum Albumin Nanoparticles with High-Entrapment Efficiency for Targeting Urinary Tract Infections"],"prefix":"10.1208","volume":"26","author":[{"given":"Sof\u00eda V.","family":"S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erlen","family":"Cruz Jorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s","family":"Navarro M.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"V\u00e1squez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Del Canto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Scavone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva C.","family":"Arr\u00faa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3190-2168","authenticated-orcid":false,"given":"Javier O.","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"3115_CR1","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.2147\/IDR.S402279","volume":"16","author":"Y Gebretensaie","year":"2023","unstructured":"Gebretensaie Y, Atnafu A, Girma S, Alemu Y, Desta K. Prevalence of bacterial urinary tract infection, associated risk factors, and antimicrobial resistance pattern in addis ababa, ethiopia: a cross-sectional study. Infect Drug Resist. 2023;16:3041\u201350.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"3115_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/QCO.0000000000000127","volume":"28","author":"G Godaly","year":"2015","unstructured":"Godaly G, Ambite I, Svanborg C. Innate immunity and genetic determinants of urinary tract infection susceptibility. Curr Opin Infect Dis. 2015;28(1):88\u201396.","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"3115_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","volume":"28","author":"B Foxman","year":"2014","unstructured":"Foxman B. Urinary tract infection syndromes. Infect Dis Clin North Am. 2014;28(1):1\u201313.","journal-title":"Infect Dis Clin North Am"},{"issue":"1","key":"3115_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1039\/D2BM01276F","volume":"11","author":"A Banerjee","year":"2023","unstructured":"Banerjee A, Chowdhury P, Bauri K, Saha B, De P. Inhibition and eradication of bacterial biofilm using polymeric materials. Biomater Sci. 2023;11(1):11\u201336.","journal-title":"Biomater Sci"},{"issue":"3","key":"3115_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/antibiotics8030092","volume":"8","author":"MS Haugan","year":"2019","unstructured":"Haugan MS, Hertz FB, Charbon G, Sahin B, L\u00f8bner-Olesen A, Frimodt-M\u00f8ller N. Growth rate of escherichia coli during human urinary tract infection: implications for antibiotic effect. Antibiotics. 2019;8(3):92.","journal-title":"Antibiotics"},{"issue":"5","key":"3115_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269\u201384.","journal-title":"Nat Rev Microbiol"},{"issue":"9","key":"3115_CR7","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3390\/medicina57090872","volume":"57","author":"M Guliciuc","year":"2021","unstructured":"Guliciuc M, Maier AC, Maier IM, Kraft A, Cucuruzac RR, Marinescu M, et al. The urosepsis\u2014a literature review. Medicina (Kaunas). 2021;57(9):872.","journal-title":"Medicina (Kaunas)"},{"issue":"6","key":"3115_CR8","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/s00120-022-01832-5","volume":"61","author":"J Kranz","year":"2022","unstructured":"Kranz J, Stangl F, Kuppe C, Wagenlehner F, Saar M, Schneidewind L. Urosepsis-targeted diagnostics and effective therapy. Urologie. 2022;61(6):596\u2013601.","journal-title":"Urologie"},{"issue":"s2","key":"3115_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1365-2362.2008.02008.x","volume":"38","author":"FME Wagenlehner","year":"2008","unstructured":"Wagenlehner FME, Pilatz A, Naber KG, Weidner W. Therapeutic challenges of urosepsis. Eur J Clin Invest. 2008;38(s2):45\u20139.","journal-title":"Eur J Clin Invest"},{"key":"3115_CR10","first-page":"109","volume":"14","author":"GT Werneburg","year":"2022","unstructured":"Werneburg GT. Catheter-associated urinary tract infections: current challenges and future prospects. Res Rep Urol. 2022;14:109\u201333.","journal-title":"Res Rep Urol"},{"issue":"1","key":"3115_CR11","doi-asserted-by":"publisher","first-page":"01","DOI":"10.31579\/2642-9756\/008","volume":"2","author":"K Clarke","year":"2019","unstructured":"Clarke K. Catheter-associated urinary tract infections: diagnosis, treatment, and prevention. Women Health Care Issues. 2019;2(1):01\u20134.","journal-title":"Women Health Care Issues"},{"issue":"2","key":"3115_CR12","doi-asserted-by":"publisher","first-page":"e2020012138","DOI":"10.1542\/peds.2020-012138","volume":"147","author":"TK Mattoo","year":"2021","unstructured":"Mattoo TK, Shaikh N, Nelson CP. Contemporary management of urinary tract infection in children. Pediatrics. 2021;147(2):e2020012138.","journal-title":"Pediatrics"},{"key":"3115_CR13","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3389\/fphar.2017.00546","volume":"8","author":"D Sharma","year":"2017","unstructured":"Sharma D, Patel RP, Zaidi STR, Sarker MdMR, Lean QY, Ming LC. Interplay of the quality of ciprofloxacin and antibiotic resistance in developing countries. Front Pharmacol. 2017;8:546.","journal-title":"Front Pharmacol."},{"key":"3115_CR14","doi-asserted-by":"publisher","first-page":"7656752","DOI":"10.1155\/2018\/7656752","volume":"2018","author":"DS Lee","year":"2018","unstructured":"Lee DS, Lee SJ, Choe HS. Community-acquired urinary tract infection by escherichia coli in the era of antibiotic resistance. Biomed Res Int. 2018;2018:7656752.","journal-title":"Biomed Res Int"},{"key":"3115_CR15","first-page":"11","volume":"19","author":"SV S\u00e1nchez","year":"2021","unstructured":"S\u00e1nchez SV, Navarro N, Catal\u00e1n-Figueroa J, Morales JO. Nanoparticles as potential novel therapies for urinary tract infections. Front Cell Infect Microbiol. 2021;19:11.","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"3115_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11095-019-2692-6","volume":"36","author":"M Rawal","year":"2019","unstructured":"Rawal M, Singh A, Amiji MM. Quality-by-design concepts to improve nanotechnology-based drug development. Pharm Res. 2019;36(11):153.","journal-title":"Pharm Res"},{"key":"3115_CR17","first-page":"9","volume":"13","author":"MM Mamun","year":"2021","unstructured":"Mamun MM, Sorinolu AJ, Munir M, Vejerano EP. Nanoantibiotics: functions and properties at the nanoscale to combat antibiotic resistance. Front Chem. 2021;13:9.","journal-title":"Front Chem"},{"key":"3115_CR18","doi-asserted-by":"crossref","unstructured":"Ovais M, Zia N, Khalil AT, Ayaz M, Khalil A, Ahmad I. Nanoantibiotics: Recent Developments and Future Prospects. 2019; pp 158\u201382.","DOI":"10.2174\/9781681086378119050006"},{"issue":"12","key":"3115_CR19","doi-asserted-by":"publisher","first-page":"8060","DOI":"10.1021\/acsabm.1c00832","volume":"4","author":"SA Polash","year":"2021","unstructured":"Polash SA, Khare T, Kumar V, Shukla R. Prospects of exploring the metal-organic framework for combating antimicrobial resistance. ACS Appl Bio Mater. 2021;4(12):8060\u201379.","journal-title":"ACS Appl Bio Mater"},{"issue":"14","key":"3115_CR20","doi-asserted-by":"publisher","first-page":"13450","DOI":"10.1021\/acsami.9b02279","volume":"11","author":"S Ranjan Sarker","year":"2019","unstructured":"Ranjan Sarker S, Polash SA, Boath J, Kandjani AE, Poddar A, Dekiwadia C, et al. Functionalization of elongated tetrahexahedral au nanoparticles and their antimicrobial activity assay. ACS Appl Mater Interfaces. 2019;11(14):13450\u20139.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"2","key":"3115_CR21","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1021\/acsabm.1c00902","volume":"5","author":"SR Sarker","year":"2022","unstructured":"Sarker SR, Polash SA, Karim MN, Saha T, Dekiwadia C, Bansal V, et al. Functionalized concave cube gold nanoparticles as potent antimicrobial agents against pathogenic bacteria. ACS Appl Bio Mater. 2022;5(2):492\u2013503.","journal-title":"ACS Appl Bio Mater"},{"key":"3115_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cis.2017.06.010","volume":"249","author":"MS Kumar","year":"2017","unstructured":"Kumar MS, Das AP. Emerging nanotechnology based strategies for diagnosis and therapeutics of urinary tract infections: A review. Adv Coll Interface Sci. 2017;249:53\u201365.","journal-title":"Adv Coll Interface Sci"},{"issue":"1","key":"3115_CR23","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s43094-021-00345-w","volume":"7","author":"P Yadav","year":"2021","unstructured":"Yadav P, Yadav AB. Preparation and characterization of BSA as a model protein loaded chitosan nanoparticles for the development of protein-\/peptide-based drug delivery system. Future J Pharm Sci. 2021;7(1):200.","journal-title":"Future J Pharm Sci"},{"issue":"3","key":"3115_CR24","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3390\/ma11030394","volume":"11","author":"M Tarhini","year":"2018","unstructured":"Tarhini M, Benlyamani I, Hamdani S, Agusti G, Fessi H, Greige-Gerges H, et al. Protein-based nanoparticle preparation via nanoprecipitation method. Materials (Basel). 2018;11(3):394.","journal-title":"Materials (Basel)"},{"issue":"1","key":"3115_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jconrel.2012.04.036","volume":"161","author":"AO Elzoghby","year":"2012","unstructured":"Elzoghby AO, Samy WM, Elgindy NA. Protein-based nanocarriers as promising drug and gene delivery systems. J Control Release. 2012;161(1):38\u201349.","journal-title":"J Control Release"},{"issue":"10","key":"3115_CR26","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.2174\/1381612822666160125114900","volume":"22","author":"A Loureiro","year":"2016","unstructured":"Loureiro A, Azoiaa NG, Gomes AC, Cavaco-Paul A. Albumin-based nanodevices as drug carriers. Curr Pharm Des. 2016;22(10):1371\u201390.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"3115_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40199-016-0153-x","volume":"24","author":"B Ramaiah","year":"2016","unstructured":"Ramaiah B, Nagaraja SH, Kapanigowda UG, Boggarapu PR, Subramanian R. High azithromycin concentration in lungs by way of bovine serum albumin microspheres as targeted drug delivery: lung targeting efficiency in albino mice. DARU J Pharm Sci. 2016;24(1):14.","journal-title":"DARU J Pharm Sci"},{"issue":"6","key":"3115_CR28","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1080\/02652040110055298","volume":"18","author":"FQ Li","year":"2001","unstructured":"Li FQ, Hu JH, Lu B, Yao H, Zhang WG. Ciprofloxacin-loaded bovine serum albumin microspheres: preparation and drug-release in vitro. J Microencapsul. 2001;18(6):825\u20139.","journal-title":"J Microencapsul"},{"issue":"1","key":"3115_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0378-5173(99)00370-1","volume":"194","author":"C Weber","year":"2000","unstructured":"Weber C, Coester C, Kreuter J, Langer K. Desolvation process and surface characterisation of protein nanoparticles. Int J Pharm. 2000;194(1):91\u2013102.","journal-title":"Int J Pharm"},{"issue":"1","key":"3115_CR30","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijpharm.2017.11.024","volume":"536","author":"N Taneja","year":"2018","unstructured":"Taneja N, Singh KK. Rational design of polysorbate 80 stabilized human serum albumin nanoparticles tailored for high drug loading and entrapment of irinotecan. Int J Pharm. 2018;536(1):82\u201394.","journal-title":"Int J Pharm"},{"key":"3115_CR31","doi-asserted-by":"crossref","unstructured":"Yuangyai C, Nembhard HB. Chapter 8 - Design of Experiments: A Key to Innovation in Nanotechnology. In: Ahmed W, Jackson MJ, editors. Emerging Nanotechnologies for Manufacturing [Internet]. Boston: William Andrew Publishing. 2010 [cited 2024 Apr 29], pp 207\u201334. (Micro and Nano Technologies). Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780815515838000089.","DOI":"10.1016\/B978-0-8155-1583-8.00008-9"},{"key":"3115_CR32","doi-asserted-by":"crossref","unstructured":"Leonardi D, Lamas MC, Salomon CJ. A quality by design update on nano-drug delivery systems. 2023. pp 117\u201338.","DOI":"10.1007\/978-3-031-31505-3_6"},{"key":"3115_CR33","unstructured":"Goicoechea HC. Introduction to Quality by Design in Pharmaceutical Manufacturing and Analytical Development. Breitkreitz MC, Goicoechea H (eds.) Cham: Springer International Publishing; 2023; pp 1\u2013268. (AAPS Introductions in the Pharmaceutical Sciences; vol. 10)."},{"key":"3115_CR34","doi-asserted-by":"publisher","first-page":"542755","DOI":"10.3389\/fcimb.2020.542755","volume":"10","author":"MJ Gonz\u00e1lez","year":"2020","unstructured":"Gonz\u00e1lez MJ, Zunino P, Scavone P, Robino L. Selection of effective antibiotics for uropathogenic escherichia coli intracellular bacteria reduction. Front Cell Infect Microbiol. 2020;10:542755.","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"3115_CR35","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1093\/cid\/ciu634","volume":"59","author":"L Robino","year":"2014","unstructured":"Robino L, Scavone P, Araujo L, Algorta G, Zunino P, P\u00edrez MC, et al. Intracellular bacteria in the pathogenesis of escherichia coli urinary tract infection in children. Clin Infect Dis. 2014;59(11):e158\u201364.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"3115_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2478\/v10007-011-0012-8","volume":"61","author":"A Bansal","year":"2011","unstructured":"Bansal A, Kapoor D, Kapil R, Chhabra N, Dhawan S. Design and development of paclitaxel-loaded bovine serum albumin nanoparticles for brain targeting. Acta Pharm. 2011;61(2):141\u201356.","journal-title":"Acta Pharm"},{"issue":"5","key":"3115_CR37","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1208\/s12249-019-1419-7","volume":"20","author":"F Arriagada","year":"2019","unstructured":"Arriagada F, G\u00fcnther G, Zabala I, Rubio-Retama J, Morales J. Development and characterization of florfenicol-loaded BSA nanoparticles as controlled release carrier. AAPS PharmSciTech. 2019;20(5):202.","journal-title":"AAPS PharmSciTech"},{"issue":"12","key":"3115_CR38","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.3390\/cancers13123011","volume":"13","author":"R Prajapati","year":"2021","unstructured":"Prajapati R, Garcia-Garrido E, Somoza \u00c1. Albumin-based nanoparticles for the delivery of doxorubicin in breast cancer. Cancers. 2021;13(12):3011.","journal-title":"Cancers"},{"issue":"1\u20133","key":"3115_CR39","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.colsurfa.2011.07.032","volume":"389","author":"G Moreno-Bautista","year":"2011","unstructured":"Moreno-Bautista G, Tam KC. Evaluation of dialysis membrane process for quantifying the in vitro drug-release from colloidal drug carriers. Colloids Surf, A. 2011;389(1\u20133):299\u2013303.","journal-title":"Colloids Surf, A"},{"key":"3115_CR40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ejpb.2016.12.015","volume":"116","author":"R Schwarzl","year":"2017","unstructured":"Schwarzl R, Du F, Haag R, Netz RR. General method for the quantification of drug loading and release kinetics of nanocarriers. Eur J Pharm Biopharm. 2017;116:131\u20137.","journal-title":"Eur J Pharm Biopharm"},{"key":"3115_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jconrel.2019.09.016","volume":"315","author":"M Yu","year":"2019","unstructured":"Yu M, Yuan W, Li D, Schwendeman A, Schwendeman SP. Predicting drug release kinetics from nanocarriers inside dialysis bags. J Control Release. 2019;315:23\u201330.","journal-title":"J Control Release"},{"issue":"3","key":"3115_CR42","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","volume":"12","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Huo M, Zhou J, Zou A, Li W, Yao C, et al. DDSolver: An add-in program for modeling and comparison of drug dissolution profiles. AAPS Journal. 2010;12(3):263\u201371.","journal-title":"AAPS Journal"},{"key":"3115_CR43","doi-asserted-by":"crossref","unstructured":"Pr\u00e4bst K, Engelhardt H, Ringgeler S, H\u00fcbner H. Basic Colorimetric Proliferation Assays: MTT, WST, and Resazurin. In 2017, pp 1\u201317.","DOI":"10.1007\/978-1-4939-6960-9_1"},{"issue":"2","key":"3115_CR44","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1046\/j.1365-2958.1998.01061.x","volume":"30","author":"LA Pratt","year":"1998","unstructured":"Pratt LA, Kolter R. Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili. Mol Microbiol. 1998;30(2):285\u201393.","journal-title":"Mol Microbiol"},{"issue":"2","key":"3115_CR45","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/elps.200305754","volume":"25","author":"BJ Kirby","year":"2004","unstructured":"Kirby BJ, Hasselbrink EF. Zeta potential of microfluidic substrates: 1. Theory, experimental techniques, and effects on separations. Electrophoresis. 2004;25(2):187\u2013202.","journal-title":"Electrophoresis."},{"issue":"213","key":"3115_CR46","doi-asserted-by":"publisher","first-page":"112403","DOI":"10.1016\/j.colsurfb.2022.112403","volume":"1","author":"EC Arrua","year":"2022","unstructured":"Arrua EC, Sanchez SV, Trincado V, Hidalgo A, Quest AFG, Morales JO. Experimental design and optimization of a novel dual-release drug delivery system with therapeutic potential against infection with Helicobacter pylori. Colloids Surf, B. 2022;1(213):112403.","journal-title":"Colloids Surf, B"},{"key":"3115_CR47","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.ijbiomac.2016.06.014","volume":"91","author":"RA Hashad","year":"2016","unstructured":"Hashad RA, Ishak RAH, Geneidi AS, Mansour S. Methotrexate loading in chitosan nanoparticles at a novel pH: Response surface modeling, optimization and characterization. Int J Biol Macromol. 2016;91:630\u20139.","journal-title":"Int J Biol Macromol"},{"issue":"1\u20132","key":"3115_CR48","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ijpharm.2008.09.036","volume":"367","author":"D Leonardi","year":"2009","unstructured":"Leonardi D, Salom\u00f3n CJ, Lamas MC, Olivieri AC. Development of novel formulations for Chagas\u2019 disease: Optimization of benznidazole chitosan microparticles based on artificial neural networks. Int J Pharm. 2009;367(1\u20132):140\u20137.","journal-title":"Int J Pharm"},{"issue":"1","key":"3115_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12249-012-9878-0","volume":"14","author":"M Agarkhed","year":"2013","unstructured":"Agarkhed M, O\u2019Dell C, Hsieh MC, Zhang J, Goldstein J, Srivastava A. Effect of polysorbate 80 concentration on thermal and photostability of a monoclonal antibody. AAPS PharmSciTech. 2013;14(1):1\u20139.","journal-title":"AAPS PharmSciTech"},{"key":"3115_CR50","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ejpb.2015.09.016","volume":"97","author":"TA Khan","year":"2015","unstructured":"Khan TA, Mahler HC, Kishore RSK. Key interactions of surfactants in therapeutic protein formulations: A review. Eur J Pharm Biopharm. 2015;97:60\u20137.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1\u20132","key":"3115_CR51","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bpc.2009.04.004","volume":"143","author":"P Garidel","year":"2009","unstructured":"Garidel P, Hoffmann C, Blume A. A thermodynamic analysis of the binding interaction between polysorbate 20 and 80 with human serum albumins and immunoglobulins: a contribution to understand colloidal protein stabilisation. Biophys Chem. 2009;143(1\u20132):70\u20138.","journal-title":"Biophys Chem"},{"issue":"21","key":"3115_CR52","first-page":"2809","volume":"11","author":"AA Sidhaye","year":"2016","unstructured":"Sidhaye AA, Bhuran KC, Zambare S, Abubaker M, Nirmalan N, Singh KK. Bio-inspired artemether-loaded human serum albumin nanoparticles for effective control of malaria-infected erythrocytes. Nanomedicine. 2016;11(21):2809\u201328.","journal-title":"Nanomedicine"},{"issue":"1","key":"3115_CR53","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijpharm.2017.11.024","volume":"536","author":"N Taneja","year":"2018","unstructured":"Taneja N, Singh KK. Rational design of polysorbate 80 stabilized human serum albumin nanoparticles tailored for high drug loading and entrapment of irinotecan. Int J Pharm. 2018;536(1):82\u201394.","journal-title":"Int J Pharm"},{"key":"3115_CR54","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ejpb.2023.07.008","volume":"190","author":"P Famta","year":"2023","unstructured":"Famta P, Shah S, Vambhurkar G, Srinivasarao DA, Jain N, Begum N, et al. Quality by design endorsed fabrication of Ibrutinib-loaded human serum albumin nanoparticles for the management of leukemia. Eur J Pharm Biopharm. 2023;190:94\u2013106.","journal-title":"Eur J Pharm Biopharm"},{"issue":"8","key":"3115_CR55","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.2174\/1567201818666210202104810","volume":"18","author":"A Kumar","year":"2021","unstructured":"Kumar A, Singh A, Flora SJS, Shukla R. Box-behnken design optimized TPGS coated bovine serum albumin nanoparticles loaded with anastrozole. Curr Drug Deliv. 2021;18(8):1136\u201347.","journal-title":"Curr Drug Deliv"},{"issue":"10","key":"3115_CR56","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3109\/03639045.2011.563781","volume":"37","author":"L Li","year":"2011","unstructured":"Li L, Zhao X, Yang C, Hu H, Qiao M, Chen D. Preparation and optimization of doxorubicin-loaded albumin nanoparticles using response surface methodology. Drug Dev Ind Pharm. 2011;37(10):1170\u201380.","journal-title":"Drug Dev Ind Pharm"},{"key":"3115_CR57","doi-asserted-by":"publisher","first-page":"103411","DOI":"10.1016\/j.jddst.2022.103411","volume":"72","author":"SS El Tokhy","year":"2022","unstructured":"El Tokhy SS, Elgizawy SA, Osman MA, Goda AE, Unsworth LD. Tailoring dexamethasone loaded albumin nanoparticles: A full factorial design with enhanced anti-inflammatory activity In vivo. J Drug Deliv Sci Technol. 2022;72:103411.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"5","key":"3115_CR58","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.3390\/pharmaceutics15051425","volume":"15","author":"MS Attia","year":"2023","unstructured":"Attia MS, Radwan MF, Ibrahim TS, Ibrahim TM. Development of carvedilol-loaded albumin-based nanoparticles with factorial design to optimize in vitro and in vivo performance. Pharmaceutics. 2023;15(5):1425.","journal-title":"Pharmaceutics"},{"issue":"9","key":"3115_CR59","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cherd.2013.11.024","volume":"92","author":"H Kouchakzadeh","year":"2014","unstructured":"Kouchakzadeh H, Shojaosadati SA, Shokri F. Efficient loading and entrapment of tamoxifen in human serum albumin based nanoparticulate delivery system by a modified desolvation technique. Chem Eng Res Des. 2014;92(9):1681\u201392.","journal-title":"Chem Eng Res Des"},{"key":"3115_CR60","doi-asserted-by":"publisher","first-page":"6945","DOI":"10.2147\/IJN.S467876","volume":"19","author":"N Qu","year":"2024","unstructured":"Qu N, Song K, Ji Y, Liu M, Chen L, Lee RJ, et al. Albumin nanoparticle-based drug delivery systems. Int J Nanomedicine. 2024;19:6945\u201380.","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"3115_CR61","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3390\/pharmaceutics17030350","volume":"17","author":"MM Faisal","year":"2025","unstructured":"Faisal MM, Gomaa E, Attia MS, Abdelnaby RM, Ibrahim AE, Al-Harrasi A, et al. Albumin-based nanoparticles with factorial design as a promising approach for remodeled repaglinide: evidence from in silico, in vitro, and in vivo evaluations. Pharmaceutics. 2025;17(3):350.","journal-title":"Pharmaceutics"},{"issue":"349","key":"3115_CR62","doi-asserted-by":"publisher","first-page":"118183","DOI":"10.1016\/j.molliq.2021.118183","volume":"1","author":"PP Madeira","year":"2022","unstructured":"Madeira PP, Rocha ILD, Rosa ME, Freire MG, Coutinho JAP. On the aggregation of bovine serum albumin. J Mol Liq. 2022;1(349):118183.","journal-title":"J Mol Liq"},{"issue":"1","key":"3115_CR63","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jbm.b.30994","volume":"86","author":"D Jain","year":"2008","unstructured":"Jain D, Banerjee R. Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery. J Biomed Mater Res B Appl Biomater. 2008;86(1):105\u201312.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"3115_CR64","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/NSA.S441324","volume":"17","author":"YP Tanjung","year":"2024","unstructured":"Tanjung YP, Dewi MK, Gatera VA, Barliana MI, Joni IM, Chaerunisaa AY. Factors affecting the synthesis of bovine serum albumin nanoparticles using the desolvation method. Nanotechnol Sci Appl. 2024;17:21\u201340.","journal-title":"Nanotechnol Sci Appl"},{"issue":"2","key":"3115_CR65","first-page":"255","volume":"12","author":"S Honary","year":"2013","unstructured":"Honary S, Zahir F. Effect of zeta potential on the properties of nano-drug delivery systems - a review (Part 1). Trop J Pharm Res. 2013;12(2):255\u201364.","journal-title":"Trop J Pharm Res"},{"key":"3115_CR66","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jddst.2018.07.018","volume":"47","author":"S Sun","year":"2018","unstructured":"Sun S, Xiao QR, Wang Y, Jiang Y. Roles of alcohol desolvating agents on the size control of bovine serum albumin nanoparticles in drug delivery system. J Drug Deliv Sci Technol. 2018;47:193\u20139.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"2","key":"3115_CR67","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.foodchem.2013.04.059","volume":"141","author":"SYR Paik","year":"2013","unstructured":"Paik SYR, Nguyen HH, Ryu J, Che JH, Kang TS, Lee JK, et al. Robust size control of bovine serum albumin (BSA) nanoparticles by intermittent addition of a desolvating agent and the particle formation mechanism. Food Chem. 2013;141(2):695\u2013701.","journal-title":"Food Chem"},{"issue":"3","key":"3115_CR68","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3390\/ma11030394","volume":"11","author":"M Tarhini","year":"2018","unstructured":"Tarhini M, Benlyamani I, Hamdani S, Agusti G, Fessi H, Greige-Gerges H, et al. Protein-based nanoparticle preparation via nanoprecipitation method. Materials. 2018;11(3):394.","journal-title":"Materials"},{"key":"3115_CR69","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.ijbiomac.2016.05.032","volume":"91","author":"A Jahanban-Esfahlan","year":"2016","unstructured":"Jahanban-Esfahlan A, Dastmalchi S, Davaran S. A simple improved desolvation method for the rapid preparation of albumin nanoparticles. Int J Biol Macromol. 2016;91:703\u20139.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"3115_CR70","doi-asserted-by":"publisher","first-page":"E118","DOI":"10.1208\/pt0801017","volume":"8","author":"PV Kumar","year":"2007","unstructured":"Kumar PV, Jain NK. Suppression of agglomeration of ciprofloxacin-loaded human serum albumin nanoparticles. AAPS PharmSciTech. 2007;8(1):E118\u201323.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"3115_CR71","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jbm.b.30994","volume":"86B","author":"D Jain","year":"2008","unstructured":"Jain D, Banerjee R. Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery. J Biomed Mater Res B Appl Biomater. 2008;86B(1):105\u201312.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"issue":"3","key":"3115_CR72","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1007\/s12247-023-09709-6","volume":"18","author":"O Esim","year":"2023","unstructured":"Esim O, Kiymaci ME, Hascicek C. Ciprofloxacin HCl-loaded albumin nanoparticles for the treatment of recurrent urinary tract infections: preparation, optimization, and evaluation of antibacterial activity. J Pharm Innov. 2023;18(3):1100\u201310.","journal-title":"J Pharm Innov"},{"key":"3115_CR73","unstructured":"Clarke SP. Development of hierarchical magnetic nanocomposite materials for biomedical applications. School Chem Sci. 2013."},{"issue":"2","key":"3115_CR74","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","volume":"10","author":"M Danaei","year":"2018","unstructured":"Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10(2):57.","journal-title":"Pharmaceutics"},{"key":"3115_CR75","doi-asserted-by":"crossref","unstructured":"Raval N, Maheshwari R, Kalyane D, Youngren-Ortiz SR, Chougule MB, Tekade RK. Importance of physicochemical characterization of nanoparticles in pharmaceutical product development. Basic Fundam Drug Deliv. 2019;369\u2013400.","DOI":"10.1016\/B978-0-12-817909-3.00010-8"},{"key":"3115_CR76","doi-asserted-by":"crossref","unstructured":"Mudalige T, Qu H, Van Haute D, Ansar SM, Paredes A, Ingle T. Characterization of nanomaterials: Tools and challenges. In: Nanomaterials for Food Applications. Elsevier. 2018, pp 313\u201353.","DOI":"10.1016\/B978-0-12-814130-4.00011-7"},{"key":"3115_CR77","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/NSA.S117018","volume":"10","author":"ES Bronze-Uhle","year":"2016","unstructured":"Bronze-Uhle ES, Costa BC, Ximenes VF, Lisboa-Filho PN. Synthetic nanoparticles of bovine serum albumin with entrapped salicylic acid. Nanotechnol Sci Appl. 2016;10:11\u201321.","journal-title":"Nanotechnol Sci Appl"},{"key":"3115_CR78","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.foodchem.2017.07.075","volume":"239","author":"Y Fan","year":"2018","unstructured":"Fan Y, Yi J, Zhang Y, Yokoyama W. Fabrication of curcumin-loaded bovine serum albumin (BSA)-dextran nanoparticles and the cellular antioxidant activity. Food Chem. 2018;239:1210\u20138.","journal-title":"Food Chem"},{"issue":"26","key":"3115_CR79","doi-asserted-by":"publisher","first-page":"6075","DOI":"10.1021\/acs.jafc.5b01778","volume":"63","author":"JL Feng","year":"2015","unstructured":"Feng JL, Qi JR, Yin SW, Wang JM, Guo J, Weng JY, et al. Fabrication and characterization of stable soy \u03b2-Conglycinin\u2013Dextran core-shell nanogels prepared via a self-assembly approach at the isoelectric point. J Agric Food Chem. 2015;63(26):6075\u201383.","journal-title":"J Agric Food Chem"},{"key":"3115_CR80","doi-asserted-by":"crossref","unstructured":"Bruschi ML. Mathematical models of drug release. In: Strategies to Modify the Drug Release from Pharmaceutical Systems. Elsevier. 2015; pp 63\u201386.","DOI":"10.1016\/B978-0-08-100092-2.00005-9"},{"key":"3115_CR81","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13104-017-2507-y","volume":"10","author":"MdS Uddin","year":"2017","unstructured":"Uddin MdS, Mamun AA, Hossain MdS, Asaduzzaman Md, Sarwar MdS, Rashid M, et al. In vitro quality evaluation of leading brands of ciprofloxacin tablets available in Bangladesh. BMC Res Notes. 2017;10:185.","journal-title":"BMC Res Notes"},{"issue":"1","key":"3115_CR82","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0378-4274(01)00509-4","volume":"127","author":"R Stahlmann","year":"2002","unstructured":"Stahlmann R. Clinical toxicological aspects of fluoroquinolones. Toxicol Lett. 2002;127(1):269\u201377.","journal-title":"Toxicol Lett"},{"issue":"5","key":"3115_CR83","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/S0026-895X(25)09546-X","volume":"50","author":"JW Lawrence","year":"1996","unstructured":"Lawrence JW, Claire DC, Weissig V, Rowe TC. Delayed cytotoxicity and cleavage of mitochondrial DNA in ciprofloxacin-treated mammalian cells. Mol Pharmacol. 1996;50(5):1178\u201388.","journal-title":"Mol Pharmacol"},{"issue":"12","key":"3115_CR84","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1191\/0960327102ht305oa","volume":"21","author":"A G\u00fcrbay","year":"2002","unstructured":"G\u00fcrbay A, Garrel C, Osman M, Richard MJ, Favier A, Hincal F. Cytotoxicity in ciprofloxacin-treated human fibroblast cells and protection by vitamin E. Hum Exp Toxicol. 2002;21(12):635\u201341.","journal-title":"Hum Exp Toxicol"},{"issue":"1","key":"3115_CR85","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/14756366.2022.2136172","volume":"38","author":"HK Swedan","year":"2023","unstructured":"Swedan HK, Kassab AE, Gedawy EM, Elmeligie SE. Design, synthesis, and biological evaluation of novel ciprofloxacin derivatives as potential anticancer agents targeting topoisomerase II enzyme. J Enzyme Inhib Med Chem. 2023;38(1):118\u201337.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"1","key":"3115_CR86","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1049\/iet-nbt.2019.0086","volume":"14","author":"V Ziaaddini","year":"2020","unstructured":"Ziaaddini V, Saeidifar M, Eslami-Moghadam M, Saberi M, Mozafari M. Improvement of efficacy and decrement cytotoxicity of oxaliplatin anticancer drug using bovine serum albumin nanoparticles: synthesis, characterisation and release behaviour. IET Nanobiotechnol. 2020;14(1):105\u201311.","journal-title":"IET Nanobiotechnol"},{"issue":"4","key":"3115_CR87","first-page":"930","volume":"3","author":"I Hassanin","year":"2020","unstructured":"Hassanin I, Elzoghby A. Albumin-based nanoparticles: a promising strategy to overcome cancer drug resistance. Cancer Drug Resist. 2020;3(4):930\u201346.","journal-title":"Cancer Drug Resist"},{"key":"3115_CR88","doi-asserted-by":"publisher","first-page":"101471","DOI":"10.1016\/j.jddst.2019.101471","volume":"55","author":"E Karami","year":"2020","unstructured":"Karami E, Behdani M, Kazemi-Lomedasht F. Albumin nanoparticles as nanocarriers for drug delivery: Focusing on antibody and nanobody delivery and albumin-based drugs. J Drug Deliv Sci Technol. 2020;55:101471.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"12","key":"3115_CR89","doi-asserted-by":"publisher","first-page":"10183","DOI":"10.1166\/jnn.2015.11694","volume":"15","author":"DM Casa","year":"2015","unstructured":"Casa DM, Karam TK, de Cristo Soares Alves A, Zgoda AA, Khalil NM, Mainardes RM. Bovine serum albumin nanoparticles containing amphotericin b: characterization, cytotoxicity and in vitro antifungal evaluation. J Nanosci Nanotechnol. 2015;15(12):10183\u20138.","journal-title":"J Nanosci Nanotechnol"},{"issue":"11","key":"3115_CR90","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3390\/gels8110750","volume":"8","author":"SA Mardikasari","year":"2022","unstructured":"Mardikasari SA, Budai-Sz\u0171cs M, Orosz L, Buri\u00e1n K, Cs\u00f3ka I, Katona G. Development of thermoresponsive-gel-matrix-embedded amoxicillin trihydrate-loaded bovine serum albumin nanoparticles for local intranasal therapy. Gels. 2022;8(11):750.","journal-title":"Gels"},{"issue":"1","key":"3115_CR91","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/antibiotics10010057","volume":"10","author":"S Scutera","year":"2021","unstructured":"Scutera S, Argenziano M, Sparti R, Bessone F, Bianco G, Bastiancich C, et al. Enhanced antimicrobial and antibiofilm effect of new colistin-loaded human albumin nanoparticles. Antibiotics (Basel). 2021;10(1):57.","journal-title":"Antibiotics (Basel)"},{"issue":"10","key":"3115_CR92","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2217\/nnm-2022-0239","volume":"18","author":"EC Jorge","year":"2023","unstructured":"Jorge EC, Mart\u00ednez NN, Gonz\u00e1lez MJ, S\u00e1nchez SV, Robino L, Morales JO, et al. Gold-, silver- and magnesium-doped zinc oxide nanoparticles prevents the formation of and eradicates bacterial biofilms. Nanomedicine (Lond). 2023;18(10):803\u201318.","journal-title":"Nanomedicine (Lond)"},{"issue":"1","key":"3115_CR93","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/1040841X.2020.1842325","volume":"47","author":"W Yin","year":"2021","unstructured":"Yin W, Xu S, Wang Y, Zhang Y, Chou SH, Galperin MY, et al. Ways to control harmful biofilms: prevention, inhibition, and eradication. Crit Rev Microbiol. 2021;47(1):57\u201378.","journal-title":"Crit Rev Microbiol"},{"issue":"8","key":"3115_CR94","first-page":"1110","volume":"12","author":"ST Asma","year":"2022","unstructured":"Asma ST, Imre K, Morar A, Herman V, Acaroz U, Mukhtar H, et al. An overview of biofilm formation-combating strategies and mechanisms of action of antibiofilm agents. Life (Basel). 2022;12(8):1110.","journal-title":"Life (Basel)"},{"issue":"3","key":"3115_CR95","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3390\/pathogens11030292","volume":"11","author":"L Shrestha","year":"2022","unstructured":"Shrestha L, Fan HM, Tao HR, Huang JD. Recent strategies to combat biofilms using antimicrobial agents and therapeutic approaches. Pathogens. 2022;11(3):292.","journal-title":"Pathogens"},{"key":"3115_CR96","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2147\/IDR.S348643","volume":"15","author":"AT Yayehrad","year":"2022","unstructured":"Yayehrad AT, Wondie GB, Marew T. Different nanotechnology approaches for ciprofloxacin delivery against multidrug-resistant microbes. Infect Drug Resist. 2022;15:413\u201326.","journal-title":"Infect Drug Resist"},{"key":"3115_CR97","doi-asserted-by":"publisher","first-page":"1025633","DOI":"10.3389\/fpubh.2022.1025633","volume":"10","author":"A Shariati","year":"2022","unstructured":"Shariati A, Arshadi M, Khosrojerdi MA, Abedinzadeh M, Ganjalishahi M, Maleki A, et al. The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic. Front Public Health. 2022;10:1025633.","journal-title":"Front Public Health"},{"issue":"9","key":"3115_CR98","doi-asserted-by":"publisher","first-page":"737","DOI":"10.5301\/ijao.5000027","volume":"34","author":"JB Kaplan","year":"2011","unstructured":"Kaplan JB. Antibiotic-Induced Biofilm Formation. Int J Artif Organs. 2011;34(9):737\u201351.","journal-title":"Int J Artif Organs"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03115-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03115-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03115-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T17:02:59Z","timestamp":1751907779000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03115-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":98,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["3115"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03115-6","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"assertion":[{"value":"11 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare no conflicting interests and AI technology was used to improve grammar.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}],"article-number":"122"}}